德国风湿病护理的数字化转型：全国横断面调查

Digital Transformation of Rheumatology Care in Germany: Cross-Sectional National Survey.

作者信息

May Susann, Darkow Robert, Knitza Johannes, Boy Katharina, Klemm Philipp, Heinze Martin, Vuillerme Nicolas, Petit Pascal, Steffens-Korbanka Patricia, Kladny Heike, Hornig Johannes, Aries Peer, Welcker Martin, Muehlensiepen Felix

机构信息

Center for Health Services Research, Faculty of Health Sciences Brandenburg, Brandenburg Medical School Theodor Fontane, Rüdersdorf bei Berlin, Germany.

FH JOANNEUM Gesellschaft mbH, Graz, Austria.

出版信息

J Med Internet Res. 2025 Jan 6;27:e52601. doi: 10.2196/52601.

DOI:10.2196/52601

PMID:39761546

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11747535/

Abstract

BACKGROUND

In recent years, health care has undergone a rapid and unprecedented digital transformation. In many fields of specialty care, such as rheumatology, this shift is driven by the growing number of patients and limited resources, leading to increased use of digital health technologies (DHTs) to maintain high-quality clinical care. Previous studies examined user acceptance of individual DHTs in rheumatology, such as telemedicine, video consultations, and mHealth. However, it is essential to conduct cross-technology and continuous analyses of user acceptance and DHT use to maximize the benefits for all relevant stakeholders.

OBJECTIVE

This study aimed to explore the current acceptance, use, and preferences regarding DHTs among patients in rheumatology care in Germany.

METHODS

Rheumatology patients from 3 clinics in Germany were surveyed to understand their perspectives on DHTs. The survey included main themes, including acceptance, preferences, COVID-19's impact, potential, and barriers related to DHTs. The data were analyzed using descriptive statistics and correlation analysis.

RESULTS

Out of 337 participants, 53% (179/337) reported using DHTs. Specific technologies included wearables (72/337, 21%), mHealth apps (71/337, 21%), digital therapeutics (32/337, 9%), electronic prescriptions (30/337, 9%), video consultations (15/337, 4%), and at-home blood self-sampling (3/337, 1%). Nearly two-thirds (220/337, 65%) found DHTs useful, and 69% (233/337) held a generally positive attitude toward DHTs. Attitudes shifted positively during the COVID-19 pandemic for 40% (135/337) of participants. Higher education was more prevalent among DHT users (114/179, 63.7%) compared with nonusers (42/151, 27.8%; P=.02). The main potential benefits identified were location-independent use (244/337, 72%) and time-independent use (216/337, 64%). Key barriers included insufficient user knowledge (165/337, 49%) and limited information on DHTs (134/337, 40%).

CONCLUSIONS

Patient acceptance and use of DHTs in rheumatology is increasing in Germany. A prospective, standardized monitoring of digital transformation in rheumatology care is highly needed.

摘要

背景

近年来，医疗保健经历了快速且前所未有的数字化转型。在许多专科护理领域，如风湿病学，这种转变是由患者数量不断增加和资源有限所驱动的，这导致数字健康技术（DHTs）的使用增加，以维持高质量的临床护理。先前的研究考察了风湿病学中个体DHTs的用户接受度，如远程医疗、视频会诊和移动健康。然而，对用户接受度和DHT使用情况进行跨技术和持续分析，对于使所有相关利益相关者利益最大化至关重要。

目的

本研究旨在探讨德国风湿病护理患者对DHTs的当前接受度、使用情况和偏好。

方法

对德国3家诊所的风湿病患者进行调查，以了解他们对DHTs的看法。该调查包括主要主题，包括接受度、偏好、新冠疫情的影响、潜力以及与DHTs相关的障碍。使用描述性统计和相关性分析对数据进行分析。

结果

在337名参与者中，53%（179/337）报告使用过DHTs。具体技术包括可穿戴设备（72/337，21%）、移动健康应用程序（71/337，,21%）、数字疗法（32/337，9%）、电子处方（30/337，9%）、视频会诊（15/,337，4%）和家庭血液自我采样（3/337，1%）。近三分之二（220/337，65%）的人认为DHTs有用，69%（233/337）对DHTs总体持积极态度。在新冠疫情期间，40%（135/337）的参与者态度转为积极。与未使用者（42/151，27.8%；P=.02）相比，DHT使用者中受过高等教育的更为普遍（114/179，63.7%）。确定的主要潜在益处是不受地点限制的使用（244/337，72%）和不受时间限制的使用（216/337，64%）。主要障碍包括用户知识不足（165/337，49%）和关于DHTs的信息有限（134/337，40%）。